Pharmacological treatment of acute heart failure: current treatment and new targets.

about

Levosimendan: current data, clinical use and future development ROSE-AHF and lessons learned.Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.Heart failure: a disease complex with challenging therapeutics.

P2860

Q24629274-EAEDFB71-E504-453A-AFF8-E08622A62B4A Q34117741-092DECD8-135E-47EC-A28C-9C5B093B764D Q35618808-AC47EC89-D58A-4274-9688-6322D992F198 Q45035703-972BBD27-6320-48B8-B47B-74A0EA40275C

P2860

Pharmacological treatment of acute heart failure: current treatment and new targets.

Item

http://www.wikidata.org/entity/Q38122297

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacological treatment of acute heart failure: current treatment and new targets.

@en

type

Item

label

Pharmacological treatment of acute heart failure: current treatment and new targets.

@en

prefLabel

Pharmacological treatment of acute heart failure: current treatment and new targets.

@en

P1476

Pharmacological treatment of acute heart failure: current treatment and new targets.

@en

P2093

A Link

http://www.w3.org/2001/XMLSchema#string

J Pöss

http://www.w3.org/2001/XMLSchema#string

M Böhm

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal vasodilation in pregnancy: the emerging role of relaxin

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

The renal urodilatin system: clinical implications

Practical applications of intravenous diuretic therapy in decompensated heart failure

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Effect of nesiritide in patients with acute decompensated heart failure

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

P304

499-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2013.136

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23863875

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

Pharmacological treatment of acute heart failure: current treatment and new targets.

about

P2860

P2860

Pharmacological treatment of acute heart failure: current treatment and new targets.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921